. . . . . . . . . "The SGA olanzapine is considered the most appropriate, followed by quetiapine and aripiprazole. Although off-label prescription of SGAs represents a common clinical practice in accordance with a worldwide trend, the use of long-acting injection formulations was considered inappropriate by 69% of psychiatrists in our sample.Attitudes on off-label use of Quetiapine in the treatment of BPD: Highly inappropriate = 50 (24.8%); Innapropriate = 20 (9.9%); Doubt = 75 (37.1%); Appropriate = 52 (25.7%); Highly appropriate = 5 (2.5%) " . . . . . . "Adults" . . "2021-08-16T21:37:54.939568"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "irip1zShKL5sN62tQxPiEMDUs4mBXOMG06bD5NdNxz0KJoteGVqJv+skLeHN/EmHYr8m1E25rOIEnTe/wnyfErSX3CcFsn8ExjH6SOua32SqdKZnaWJx+WDkWurH5Z72qrrzEJ455HJMyv/FQn3ADaRkglOkvibSCttI9Qf2u58=" . . "2021-08-16T21:37:54.939568"^^ . . .